Abstract | BACKGROUND: HISTORY AND SIGNS: A 74-year-old female with subfoveal CNV due to ARMD presented after the second injection of bevacizumab with a symptomatic acute non-granulomatous anterior uveitis. Work-up ruled out any other aetiology. THERAPY AND OUTCOME: CONCLUSIONS:
Intravitreal injection of bevacizumab is related with the possible development of acute non-granulomatous anterior uveitis, after having excluded infectious or other causes of uveitis unrelated to the bevacizumab injection. In recent clinical trials bevacizumab-induced uveitis has been demonstrated to be a rare event. The pathogenesis remains unclear. One possible explanation is the Fc portion of the antibody, which may offer the possibility of an increased cellular immune response. This case underlines the importance to inform patients about the possibility of such an episode.
|
Authors | S Hasler, M K Schmid, C N Becht |
Journal | Klinische Monatsblatter fur Augenheilkunde
(Klin Monbl Augenheilkd)
Vol. 225
Issue 5
Pg. 446-7
(May 2008)
ISSN: 0023-2165 [Print] Germany |
Vernacular Title | Akute anteriore nichtgranulomatöse Uveitis nach intravitrealer Bevacizumab-Injektion. |
PMID | 18454394
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Bevacizumab
|
Topics |
- Aged
- Antibodies, Monoclonal
(administration & dosage, adverse effects)
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Female
- Granuloma
(chemically induced, diagnosis)
- Humans
- Injections
(adverse effects)
- Uveitis, Anterior
(chemically induced, diagnosis)
- Vitreous Body
(drug effects)
|